Jump to Navigation
Trends and Sentiments
Comments and Analysis
Unilever Beats Earnings But Misses Revenues For 1HFY14
Angie’s List Misses Estimates, Issues Soft Guidance
Emerging markets slowdown hurts Unilever
Make youth appy
Roche Announces Results For 1HFY14, Confirms Guidance
German Officials Say The EU Will Hit Putin With Biting...
Hanesbrands Stock Surges On Raised Outlook
Twitter Confesses To An Imbalanced Workforce In Terms Of...
Cramer's Mad Money: The 4 Horsemen Trample Big...
Rahul Gandhi's office targetted Adani Port, says...
Are These 10 Sick Healthcare Companies Terminally Ill?
14 Oversold Stocks Trading Near Lows but Being Bought Up by the Smart Money
Top Biotech Picks of High Alpha Funds
5 Healthcare Stocks of Interest This Week
10 Stocks With Bullish Momentum Backed By Strong Top Line Growth
10 Biotech Stocks Being Dumped By Big Money Managers
3 Highly Shorted Biotech Stocks With Strong Institutional Selling
Focus On Entereg; Reiterating Buy On Adolor
Healthcor Management's Latest New And Increased Positions
5 Highly Shorted Healthcare Stocks Being Sold By Smart Money
18 Healthcare Stocks Undervalued By Target Price
10 Biotech Stocks Trading At The Deepest Discounts To Target Price
Analysis Of Institutional 5% Ownership Filings On Friday
Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
Nektar Therapeutics: Often Forgotten, But Worth A Look
12 Healthcare Stocks With Bearish Short Trends
Buy Biotech In Phase II For The Best Upside
What's It Going To Take To Get Salix Cheap?
The Age Of Personalized Medicine Has Arrived
20 Biotech Stocks Being Bought Up By Hedge Funds
A Small-Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
Long Undervalued, Is Alkermes Still A Bargain?
Why The Markets Continue To Coalesce Around New Approaches To Treating Cancer
5 Hedge Fund Biotech Stock Picks With Significant Short Covering
3M Likely To Post Earnings Beat
German Officials Say The EU Will Hit Putin With...
EUR/GBP: 1.2627 USD/EUR: 1.3474 JPY/USD: 101.615
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions